{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:04:15Z","timestamp":1791475455547,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,31]]},"DOI":"10.7759\/cureus.27529","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T23:26:42Z","timestamp":1659310002000},"source":"Crossref","is-referenced-by-count":6,"title":["Efficacy of Oral Versus Injectable Iron in Patients With Chronic Kidney Disease: A Two-Year Cross-Sectional Study Conducted at a Rural Teaching Hospital"],"prefix":"10.7759","author":[{"given":"Sachin","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Sonawane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourya","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa  A","family":"Gaidhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Wanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchita","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Phate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv109","article-title":"Chronic kidney disease hotspots in developing countries in South Asia","volume":"9","author":"Abraham G","year":"2016","unstructured":"Abraham G, Varughese S, Thandavan T, et al.. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J. 2016, 9:135-41. 10.1093\/ckj\/sfv109","journal-title":"Clin Kidney J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(01)70008-x","article-title":"","author":"NATIONAL KIDNEY FOUNDATION","year":"2001","unstructured":"NATIONAL KIDNEY FOUNDATION. NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update. 2001, 0272-6386. 10.1016\/s0272-6386(01)70008-x","journal-title":"NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/2141-9248.122052","article-title":"Do clinical symptoms and signs predict reduced renal function among hospitalized adults?","volume":"3","author":"Kumar S","year":"2013","unstructured":"Kumar S, Joshi R, Joge V. Do clinical symptoms and signs predict reduced renal function among hospitalized adults?. Ann Med Health Sci Res. 2013, 3:492-7. 10.4103\/2141-9248.122052","journal-title":"Ann Med Health Sci Res"},{"key":"ref4","article-title":"Sourya Acharya. Clinical profile of Uremic polyneuropathy in Chronic Kidney Disease patients","volume":"24","author":"Parag Aradhey","year":"2020","unstructured":"Parag Aradhey, Anand Bakre, Sunil Kumar. Sourya Acharya. Clinical profile of Uremic polyneuropathy in Chronic Kidney Disease patients. Medical Science. 2020, 24:945-951.","journal-title":"Medical Science"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.37","article-title":"Notice","volume":"2","year":"2012","unstructured":"Notice. Kidney Int Suppl (2011). 2012, 2.279. 10.1038\/kisup.2012.37","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical use of intravenous iron: administration, efficacy, and safety","volume":"2010","author":"Auerbach M","year":"2010","unstructured":"Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program. 2010, 2010:338-47. 10.1182\/asheducation-2010.1.338","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2015.07.006","article-title":"Anemia in clinical practice-definition and classification: does hemoglobin change with aging?","volume":"52","author":"Cappellini MD","year":"2015","unstructured":"Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: does hemoglobin change with aging?. Semin Hematol. 2015, 52:261-9. 10.1053\/j.seminhematol.2015.07.006","journal-title":"Semin Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/0971-4065.144421","article-title":"The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study","volume":"25","author":"Vikrant S","year":"2015","unstructured":"Vikrant S, Parashar A. The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center study. Indian J Nephrol. 2015, 25:213-21. 10.4103\/0971-4065.144421","journal-title":"Indian J Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10065-0037","article-title":"Iron-deficiency Anemia and Chronic Kidney Disease: An Overview","volume":"2","author":"Saxena R","year":"2018","unstructured":"Saxena R, Sharma G, Gulati N. Iron-deficiency Anemia and Chronic Kidney Disease: An Overview. World J. 2018, 2:85-89. 10.5005\/jp-journals-10065-0037","journal-title":"World J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.8276","article-title":"Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial","volume":"36","author":"Van Wyck DB","year":"2000","unstructured":"Van Wyck DB, Cavallo G, Spinowitz BS, Adhikarla R, Gagnon S, Charytan C, Levin N. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. Am J Kidney Dis. 2000, 36:88-97. 10.1053\/ajkd.2000.8276","journal-title":"Am J Kidney Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/18.1.141","article-title":"The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron","volume":"18","author":"Silverberg DS","year":"2003","unstructured":"Silverberg DS, Wexler D, Blum M, et al.. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant. 2003, 18:141-6. 10.1093\/ndt\/18.1.141","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations","volume":"35","author":"Silverberg DS","year":"2000","unstructured":"Silverberg DS, Wexler D, Blum M, et al.. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000, 35:1737-1744. 10.1016\/s0735-1097(00)00613-6","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.5.967","article-title":"A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin","volume":"16","author":"Stoves J","year":"2001","unstructured":"Stoves J, Inglis H, Newstead CG. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrol Dial Transplant. 2001, 16:967-74. 10.1093\/ndt\/16.5.967","journal-title":"Nephrol Dial Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000096174","article-title":"A randomized controlled trial of oral versus intravenous iron in chronic kidney disease","volume":"26","author":"Agarwal R","year":"2006","unstructured":"Agarwal R, Rizkala AR, Bastani B, Kaskas MO, Leehey DJ, Besarab A. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. Am J Nephrol. 2006, 26:445-54. 10.1159\/000096174","journal-title":"Am J Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014090922","article-title":"Considerations and challenges in defining optimal iron utilization in hemodialysis","volume":"26","author":"Charytan DM","year":"2015","unstructured":"Charytan DM, Pai AB, Chan CT, Coyne DW, Hung AM, Kovesdy CP, Fishbane S. Considerations and challenges in defining optimal iron utilization in hemodialysis. J Am Soc Nephrol. 2015, 26:1238-47. 10.1681\/ASN.2014090922","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000085049","article-title":"Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis","volume":"100","author":"Charytan C","year":"2005","unstructured":"Charytan C, Qunibi W, Bailie GR. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract. 2005, 100:c55-62. 10.1159\/000085049","journal-title":"Nephron Clin Pract"},{"key":"ref17","article-title":"Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy","volume":"51","author":"Adhikary L","year":"2011","unstructured":"Adhikary L, Acharya S. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. JNMA J Nepal Med Assoc. 2011, 51:133-6.","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal R","year":"2015","unstructured":"Agarwal R, Kusek JW, Pappas MK. A randomized trial of intravenous and oral iron in chronic kidney disease. Kidney Int. 2015, 88:905-14. 10.1038\/ki.2015.163","journal-title":"Kidney Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.05.033","article-title":"Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis","volume":"52","author":"Rozen-Zvi B","year":"2008","unstructured":"Rozen-Zvi B, Gafter-Gvili A, Paul M, Leibovici L, Shpilberg O, Gafter U. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis. Am J Kidney Dis. 2008, 52:897-906. 10.1053\/j.ajkd.2008.05.033","journal-title":"Am J Kidney Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfq613","article-title":"A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients","volume":"26","author":"Qunibi WY","year":"2011","unstructured":"Qunibi WY, Martinez C, Smith M, Benjamin J, Mangione A, Roger SD. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients. Nephrol Dial Transplant. 2011, 26:1599-607. 10.1093\/ndt\/gfq613","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu201","article-title":"FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia","volume":"29","author":"Macdougall IC","year":"2014","unstructured":"Macdougall IC, Bock AH, Carrera F, et al.. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant. 2014, 29:2075-84. 10.1093\/ndt\/gfu201","journal-title":"Nephrol Dial Transplant"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx043","article-title":"Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions","volume":"10","author":"Macdougall IC","year":"2017","unstructured":"Macdougall IC. Intravenous iron therapy in patients with chronic kidney disease: recent evidence and future directions. Clin Kidney J. 2017, 10:i16-24. 10.1093\/ckj\/sfx043","journal-title":"Clin Kidney J"},{"key":"ref23","article-title":"Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin","volume":"51","author":"Aggarwal HK","year":"2003","unstructured":"Aggarwal HK, Nand N, Singh S, Singh M, Hemant, Kaushik G. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin. J Assoc Physicians India. 2003, 51:170-4.","journal-title":"J Assoc Physicians India"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007101156","article-title":"Ferumoxytol for treating iron deficiency anemia in CKD","volume":"19","author":"Spinowitz BS","year":"2008","unstructured":"Spinowitz BS, Kausz AT, Baptista J, et al.. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol. 2008, 19:1599-605. 10.1681\/ASN.2007101156","journal-title":"J Am Soc Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD","volume":"68","author":"Van Wyck DB","year":"2005","unstructured":"Van Wyck DB, Roppolo M, Martinez CO, Mazey RM, McMurray S. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int. 2005, 68:2846-56. 10.1111\/j.1523-1755.2005.00758.x","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs528","article-title":"Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study","volume":"28","author":"Charytan C","year":"2013","unstructured":"Charytan C, Bernardo MV, Koch TA, Butcher A, Morris D, Bregman DB. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. Nephrol Dial Transplant. 2013, 28:953-64. 10.1093\/ndt\/gfs528","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv293","article-title":"A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia","volume":"31","author":"Kalra PA","year":"2016","unstructured":"Kalra PA, Bhandari S, Saxena S, et al.. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrol Dial Transplant. 2016, 31:646-55. 10.1093\/ndt\/gfv293","journal-title":"Nephrol Dial Transplant"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft251","article-title":"Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial","volume":"29","author":"Onken JE","year":"2014","unstructured":"Onken JE, Bregman DB, Harrington RA, et al.. Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. Nephrol Dial Transplant. 2014, 29:833-42. 10.1093\/ndt\/gft251","journal-title":"Nephrol Dial Transplant"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-4758.2009.00409.x","article-title":"Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia","volume":"14","author":"Bailie GR","year":"2010","unstructured":"Bailie GR, Mason NA, Valaoras TG. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Hemodial Int. 2010, 14:47-54. 10.1111\/j.1542-4758.2009.00409.x","journal-title":"Hemodial Int"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp584","article-title":"Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial","volume":"25","author":"McMahon LP","year":"2010","unstructured":"McMahon LP, Kent AB, Kerr PG, et al.. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. Nephrol Dial Transplant. 2010, 25:920-6. 10.1093\/ndt\/gfp584","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105040-efficacy-of-oral-versus-injectable-iron-in-patients-with-chronic-kidney-disease-a-two-year-cross-sectional-study-conducted-at-a-rural-teaching-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:12Z","timestamp":1707508032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105040-efficacy-of-oral-versus-injectable-iron-in-patients-with-chronic-kidney-disease-a-two-year-cross-sectional-study-conducted-at-a-rural-teaching-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.27529","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,31]]}}}